To learn more about our ongoing clinical trial or to find out if a trial is enrolling patients in your area, please visit

Candidate Phase Study Number Study Title
MDNA11 1/2 NCT05086692 ABILITY – Advanced solid tumors

At this time, Medicenna’s investigational therapy is not available on an expanded access or right-to-try basis for new patients. In the event Medicenna decides to consider expanded access or right-to-try use, the Company will evaluate and respond to each request that it receives on a case-by-case basis.